Revenue from Contract with Customer, Excluding Assessed Tax of Unity Biotechnology, Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Unity Biotechnology, Inc. annual and quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Unity Biotechnology, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 30 Jun 2023 was $0, a 100% decline year-over-year.
  • Unity Biotechnology, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $0.
  • Unity Biotechnology, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $0, a 100% decline from 2022.
  • Unity Biotechnology, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $236,000, a 95% decline from 2021.
Source SEC data
View on sec.gov
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Change (%)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Change (%)

Unity Biotechnology, Inc. Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $0 $0 01 Jan 2024 31 Dec 2024 10-K 07 Mar 2025 2024 FY
2023 $0 -$236,000 -100% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2025 2024 FY
2022 $236,000 -$4,548,000 -95% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2025 2024 FY
2021 $4,784,000 +$4,784,000 01 Jan 2021 31 Dec 2021 10-K 15 Apr 2024 2023 FY
2020 $0 $0 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2023 2022 FY
2019 $0 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2022 2021 FY

Unity Biotechnology, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $0 -$236,000 -100% 01 Apr 2023 30 Jun 2023 10-K 15 Apr 2024 2023 FY
Q3 2022 $0 $0 01 Jul 2022 30 Sep 2022 10-K 15 Apr 2024 2023 FY
Q2 2022 $236,000 +$236,000 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q3 2021 $0 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $0 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.